Amongst patients with MPN, ASXL1 mutations were frequently found in patients with advanced age and in patients with PMF and post-PV/ET MF patients than those with PV or ET [131,132,133]. This evidence concerns the gene ASXL1 and myeloproliferative neoplasm.